NCT03098251 is a NA clinical trial of 3D typing in Hepatolithiasis, sponsored by Southwest Hospital, China.

Who is sponsoring NCT03098251?

NCT03098251 is sponsored by Southwest Hospital, China.

What drugs are being tested in NCT03098251?

Interventions in NCT03098251: 3D typing, routine typing.

What condition does NCT03098251 study?

NCT03098251 studies Hepatolithiasis, Surgery.

Is NCT03098251 still recruiting?

NCT03098251 is currently status unknown. Last updated 12 April 2017.

Last reviewed 2017-04-12 · How we verify

NCT03098251

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of 3D Typing on Surgical Treatment of Hepatolithiasis

Status unknown NA Last updated 12 April 2017

What this trial tests

NA trial testing 3D typing in Hepatolithiasis in 400 participants. Status unknown.

Timeline

11 April 2017

Primary endpoint
30 December 2018

31 December 2018

Quick facts

Lead sponsor	Southwest Hospital, China
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	400
Start date	11 April 2017
Primary completion	30 December 2018
Estimated completion	31 December 2018
Sites	1 location across China

Drugs / interventions tested

3D typing
routine typing

Conditions studied

Hepatolithiasis — all drugs for Hepatolithiasis →
Surgery — all drugs for Surgery →

Sponsor

Southwest Hospital, China

Who can join

Adults 18 to 65, any sex, with Hepatolithiasis or Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

According to a large amount of case affected with hepatolithiasis, we developed a typing system of Hepatolithiasis based on 3D digital conformation. And we hypothesized that it could predict a more precise construction of this disease, hence, typing by 3D conformation will improve the outcome of surgical treatment.The investigators will use a multicenter ambispective cohort study to test this hypothesis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Southwest Hospital, China trials

Trials by the same sponsor.

NCT07469293 — Efficacy and Safety of Intra-arterial Tenecteplase in Acute Ischemic Stroke Patients With Medium Vessel Occlusion Stroke · Phase 3 · not yet recruiting
NCT07294209 — Low-Dose Tenecteplase for Acute Ischemic Stroke Treatment in Aging Patients · Phase 4 · recruiting
NCT07251374 — Osteomyelitis Multi-center Prospective Cohort Study · not yet recruiting
NCT06894433 — Efficacy and Safety of NeuroEndoscopic Surgery for Large IntraCerebral Hemorrhage · NA · recruiting
NCT06791538 — Robotic Versus Laparoscopic Radical Surgery for Locally Advanced Gastric Cancer · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03098251 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Southwest Hospital, China
Last refreshed: 12 April 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03098251.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing